Aarti Pharmalabs Ltd has been issued a Rs 59.50 crore stamp duty and penalty demand by the Gujarat stamp authorities regarding its 2022 demerger scheme. The company is contesting the order, asserting strong legal grounds to challenge the liability. Investors should watch for further updates on the appeal process, as the amount poses a potential risk to the company's cash reserves.
Aarti Pharmalabs Faces Rs 59.50 Crore Stamp Duty Demand
Total Demand: Rs 59.50 crore; Stamp Duty Liability: Rs 25 crore.
Reader Takeaway: Aarti Pharmalabs plans to legally contest a major state tax demand related to its past demerger process.
What just happened
Aarti Pharmalabs Ltd has received an order from the Office of the Superintendent of Stamps, Gandhinagar, demanding Rs 59.50 crore in stamp duty and penalties. The demand pertains to the Scheme of Arrangement involving the demerger of the Pharma Division of Aarti Industries Ltd, which was previously sanctioned by the NCLT in September 2022. The company acknowledged receiving the order on September 1, 2026.
Why this matters
The financial impact is significant for the firm's balance sheet. The demand comprises Rs 25 crore in stamp duty, another Rs 25 crore in penalties under Rule 9, and an additional Rs 9.50 crore under the Gujarat Stamp Act, 1958. This development introduces a potential financial liability that could affect cash flow if the company is unsuccessful in its legal challenge.
Management Position and Next Steps
Management has formally expressed its intent to challenge the order. The company stated it is evaluating the legal and factual grounds to contest the demand. It maintains that its position is legally robust and plans to pursue appropriate legal remedies to overturn or mitigate the penalty.
Risks to watch
The primary risk is a potential cash outflow of Rs 59.50 crore. If the legal challenge fails, the company may be required to make provisions for this amount in its financial statements, which could weigh on near-term profitability and cash availability.
What to track next
Investors should monitor future BSE filings for updates on the filing of formal appeals and any subsequent communication from the Stamp Authorities regarding the status of the legal challenge.